Cape Investment Advisory Inc. Buys 89 Shares of Veeva Systems Inc. (NYSE:VEEV)

Cape Investment Advisory Inc. grew its stake in Veeva Systems Inc. (NYSE:VEEVFree Report) by 4.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,269 shares of the technology company’s stock after buying an additional 89 shares during the quarter. Cape Investment Advisory Inc.’s holdings in Veeva Systems were worth $437,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Yousif Capital Management LLC boosted its holdings in Veeva Systems by 5.5% in the 3rd quarter. Yousif Capital Management LLC now owns 1,717 shares of the technology company’s stock worth $349,000 after buying an additional 90 shares during the period. Principal Financial Group Inc. boosted its stake in shares of Veeva Systems by 160.9% in the third quarter. Principal Financial Group Inc. now owns 73,760 shares of the technology company’s stock worth $15,006,000 after acquiring an additional 45,489 shares during the period. US Bancorp DE grew its position in shares of Veeva Systems by 3.6% during the third quarter. US Bancorp DE now owns 39,474 shares of the technology company’s stock worth $8,031,000 after purchasing an additional 1,369 shares in the last quarter. Signaturefd LLC raised its stake in Veeva Systems by 18.1% during the 3rd quarter. Signaturefd LLC now owns 1,302 shares of the technology company’s stock valued at $265,000 after purchasing an additional 200 shares during the period. Finally, Ieq Capital LLC lifted its holdings in Veeva Systems by 9.1% in the 3rd quarter. Ieq Capital LLC now owns 6,758 shares of the technology company’s stock worth $1,375,000 after purchasing an additional 566 shares in the last quarter. Institutional investors own 88.20% of the company’s stock.

Insider Transactions at Veeva Systems

In other Veeva Systems news, EVP Alan Mateo sold 3,391 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $200.86, for a total value of $681,116.26. Following the completion of the sale, the executive vice president now directly owns 21,983 shares of the company’s stock, valued at approximately $4,415,505.38. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, SVP Jonathan Faddis sold 3,598 shares of the firm’s stock in a transaction on Monday, April 15th. The stock was sold at an average price of $207.42, for a total transaction of $746,297.16. Following the transaction, the senior vice president now owns 10,668 shares in the company, valued at $2,212,756.56. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Alan Mateo sold 3,391 shares of Veeva Systems stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $200.86, for a total value of $681,116.26. Following the completion of the sale, the executive vice president now owns 21,983 shares of the company’s stock, valued at $4,415,505.38. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 21,989 shares of company stock worth $4,818,013. 10.50% of the stock is currently owned by insiders.

Veeva Systems Stock Down 0.3 %

NYSE:VEEV traded down $0.69 during mid-day trading on Friday, hitting $203.89. 600,576 shares of the stock traded hands, compared to its average volume of 664,268. The stock has a market capitalization of $32.89 billion, a price-to-earnings ratio of 63.32, a PEG ratio of 1.95 and a beta of 0.76. Veeva Systems Inc. has a 52 week low of $161.39 and a 52 week high of $236.90. The firm’s 50 day moving average is $211.14 and its two-hundred day moving average is $203.29.

Veeva Systems (NYSE:VEEVGet Free Report) last released its earnings results on Thursday, February 29th. The technology company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.81 by $0.11. Veeva Systems had a return on equity of 11.26% and a net margin of 22.24%. The firm had revenue of $630.62 million for the quarter, compared to analysts’ expectations of $620.75 million. As a group, research analysts predict that Veeva Systems Inc. will post 4.11 EPS for the current year.

Analyst Ratings Changes

VEEV has been the subject of a number of research analyst reports. KeyCorp increased their price objective on shares of Veeva Systems from $232.00 to $250.00 and gave the company an “overweight” rating in a report on Tuesday, March 5th. Piper Sandler increased their price objective on shares of Veeva Systems from $220.00 to $245.00 and gave the company an “overweight” rating in a report on Friday, March 1st. UBS Group lifted their target price on Veeva Systems from $185.00 to $235.00 and gave the stock a “neutral” rating in a report on Monday, February 26th. Stifel Nicolaus increased their price target on Veeva Systems from $205.00 to $250.00 and gave the company a “buy” rating in a research note on Friday, March 1st. Finally, Citigroup lifted their price objective on Veeva Systems from $240.00 to $264.00 and gave the stock a “buy” rating in a research note on Friday, March 1st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $234.90.

Check Out Our Latest Stock Analysis on Veeva Systems

Veeva Systems Company Profile

(Free Report)

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

Further Reading

Institutional Ownership by Quarter for Veeva Systems (NYSE:VEEV)

Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.